Orchestrated increase of dopamine and PARK mRNAs but not miR-133b in dopamine neurons in Parkinson's disease.
about
Noncoding RNA Regulation of Dopamine Signaling in Diseases of the Central Nervous SystemConverging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's diseaseGenetic mutations linked to Parkinson's disease differentially control nucleolar activity in pre-symptomatic mouse modelsMutual exacerbation of peroxisome proliferator-activated receptor γ coactivator 1α deregulation and α-synuclein oligomerizationInhibition of miR-34b and miR-34c enhances α-synuclein expression in Parkinson's disease.Increased dopamine D2 receptor activity in the striatum alters the firing pattern of dopamine neurons in the ventral tegmental area.Elevated mRNA-levels of distinct mitochondrial and plasma membrane Ca(2+) transporters in individual hypoglossal motor neurons of endstage SOD1 transgenic mice.Recent developments in circulating biomarkers in Parkinson's disease: the potential use of miRNAs in a clinical setting.Sex-specific hippocampal 5-hydroxymethylcytosine is disrupted in response to acute stress.Fifty-Hertz Magnetic Field Affects the Epigenetic Modulation of the miR-34b/c in Neuronal Cells.microRNAs in Parkinson's Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches.Cell-Specific RNA Quantification in Human SN DA Neurons from Heterogeneous Post-mortem Midbrain Samples by UV-Laser Microdissection and RT-qPCR.MicroRNAs in Parkinson's disease and emerging therapeutic targets.
P2860
Q28069604-22B42B62-0069-4B59-8C87-7C12FF9F1593Q28074143-76408AA4-8BC9-4066-84EC-42005C3248ACQ33746268-0A69ABB8-84BC-4181-A656-F8C1C03BEF9BQ34944325-B0F902F7-C342-4489-9404-EC32AB198ADBQ35014097-C89F9E3D-6D33-4EB0-8024-3826BF23B1C5Q35229331-18947EC4-D831-4BC2-82B5-1F7DB27D7F1FQ35469175-C0934B57-CD56-48EF-8AD4-AFBE7FFF5C7AQ39010887-32C50D85-F1A9-4023-ACB5-AC4A5462486AQ39439747-51AC944D-B992-4D24-ACB7-14EB45B2AF49Q46283329-0D47261A-1B58-4886-8237-0F9750368CDEQ47564833-956800B9-5FB5-4B6A-8B04-AD86B4F0B9ADQ47854637-2366A9FB-5F44-4957-B254-DB6475C90821Q47870847-5A64B43C-3BC3-4BC7-BE30-B150C2CDF775
P2860
Orchestrated increase of dopamine and PARK mRNAs but not miR-133b in dopamine neurons in Parkinson's disease.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Orchestrated increase of dopam ...... eurons in Parkinson's disease.
@ast
Orchestrated increase of dopam ...... eurons in Parkinson's disease.
@en
type
label
Orchestrated increase of dopam ...... eurons in Parkinson's disease.
@ast
Orchestrated increase of dopam ...... eurons in Parkinson's disease.
@en
prefLabel
Orchestrated increase of dopam ...... eurons in Parkinson's disease.
@ast
Orchestrated increase of dopam ...... eurons in Parkinson's disease.
@en
P2093
P2860
P50
P1476
Orchestrated increase of dopam ...... eurons in Parkinson's disease.
@en
P2093
Elena Dragicevic
Jan Gründemann
Michael Fauler
P2860
P304
P356
10.1016/J.NEUROBIOLAGING.2014.03.016
P577
2014-03-22T00:00:00Z